Neural Mechanisms of Family-Focused Treatment for Youth Depression
Neural Mechanisms of Evidence-Based, Family-Focused Treatment for Youth Depression: Preliminary Open Trial
1 other identifier
interventional
80
1 country
2
Brief Summary
The goal of this interventional study is to compare the baseline neural mechanisms and parenting in depressed and non-depressed children and to examine baseline neural mechanisms and parenting as predictors of Family-Focused Treatment for Childhood-Depression (FFT-CD) outcomes. The main questions it aims to answer are:
- What are differences between depressed and non-depressed participants on baseline neural and parenting indicators?
- Do baseline neural and parenting indicators predict response to FFT-CD?
- Does change in parenting and neural functioning mediate change in depression from baseline to follow-up? Participants will:
- complete baseline clinical measures
- complete neuroimaging tasks via Functional Magnetic Resonance Imaging (fMR)
- undergo a 12-session course of FFT-CD
- complete follow up evaluations and neuroimaging
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2024
CompletedFirst Posted
Study publicly available on registry
March 1, 2024
CompletedStudy Start
First participant enrolled
August 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2027
August 23, 2024
August 1, 2024
2.5 years
February 24, 2024
August 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Depression Treatment Response
\>/= 50% reduction on Children's Depression Rating Scale-Revised (CDRS-R). Scores on this measure range from 17 to 113, and higher scores indicate greater depression severity.
4 months (post-treatment)
Children's Self Report of Depressive Symptoms
Children's Depression Inventory (CDI) is a 28-item self-report measure. Scores range from 0 to 54 with higher scores reflecting higher levels of symptoms.
4 months
Secondary Outcomes (1)
Depression Remission
4 months
Study Arms (1)
Depressed Group
EXPERIMENTAL20 children with depression and their parents (40 participants total) will undergo a 12-session course of FFT-CD.
Interventions
This intervention includes 12 one-hour, in-person sessions. FFT-CD was designed to help families gain skills to combat depression and create ways of interacting that protect the child from the negative sequelae of stress. Within a broad psychoeducational framework, interpersonal factors impacting youth depression and the interplay of mood and interpersonal interactions are emphasized. Participants are taught to identify Upward Spirals - positive interactions fueling positive moods leading further upward - and Downward Spirals - negative interactions fueling negative moods leading further downward. The treatment rationale is "to stop downward spirals and to start upward spirals"; this idea provides a foundation for skills building to help the child and family better navigate stress. Handouts, role-playing, behavioral rehearsal, and homework assignments are all used to help shape behaviors.
Eligibility Criteria
You may qualify if:
- Children must:
- Have a current DSM-5 diagnosis of MDD, Persistent DD, or DDNOS (based on K-SADS-PL) OR not meet criteria for any DSM-5 mental health diagnosis (based on K-SADS-PL)
- Be ages 7-12
- Be living with a parent(s) or guardian willing to participate
- Be able and willing to provide informed consent/assent
- Parent must:
- Not be currently pregnant
- Be able to read, understand consent forms, and provide consent on their child's behalf
- Be the biological parent (or grandparent in parental role) of the participating child \& have lived with the child for more than 75% of the child's life.
- All participants must:
- Not have a disturbance that would interfere with participation such as autism spectrum disorder, psychosis, current substance dependence, current use of psychotropic medication, OCD, or MRI contraindication such as metal inside the body or claustrophobia
- Be proficient in English
You may not qualify if:
- Thought or other disturbance in the child that would interfere with the ability to participate in treatment or assessments (e.g., psychotic disorder, autism spectrum disorder, OCD, active substance abuse/dependence, intellectual disability, as assessed on KSADS-PL)
- Severe conduct disorders in the child that threaten the home stability (e.g. juvenile justice or children's protective service involvement as assessed on KSADS-PL) due to the potential impact on retention
- Youth or primary caregivers do not speak English
- Either parent or child has contraindications for neuroimaging (e.g., claustrophobia, metal implants, braces, electronically, magnetically, or mechanically activated devices such as cochlear implants)
- The child is on an antidepressant medication, as it may complicate neuroimaging interpretation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Boston University
Boston, Massachusetts, 02215, United States
Athinoula A. Martinos Imaging Center at Massachusetts Institute of Technology
Charlestown, Massachusetts, 02129, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 24, 2024
First Posted
March 1, 2024
Study Start
August 20, 2024
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
November 1, 2027
Last Updated
August 23, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share
These are initial pilot data and will not be shared at this time.